evans blue has been researched along with natriuretic peptide, brain in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujiwara, H; Garbers, DL; Hamanaka, I; Harada, M; Izumi, T; Kawakami, R; Kishimoto, I; Kuwahara, K; Li, Y; Mochizuki, S; Nakao, K; Saito, Y; Takahashi, N; Takemura, G | 1 |
1 other study(ies) available for evans blue and natriuretic peptide, brain
Article | Year |
---|---|
Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia/reperfusion injury.
Topics: Animals; Atrial Natriuretic Factor; Binding Sites, Antibody; Blotting, Western; Evans Blue; Guanylate Cyclase; Heart Ventricles; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Natriuretic Peptide, Brain; Neutrophils; NF-kappa B; P-Selectin; Peroxidase; Polysaccharides; Receptors, Atrial Natriuretic Factor; Signal Transduction; Time Factors; Up-Regulation | 2001 |